BlackRock Health Sciences Opportunities Portfolio Class K (SHSKX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
61.80
0.00 (0.00%)
Aug 1, 2025, 12:34 PM EDT
Fund Assets6.46B
Expense Ratio0.75%
Min. Investment$5,000,000
Turnover27.00%
Dividend (ttm)7.22
Dividend Yield11.48%
Dividend Growth85.60%
Payout FrequencySemi-Annual
Ex-Dividend DateJul 17, 2025
Previous Close61.80
YTD Return-8.27%
1-Year Return-14.45%
5-Year Return15.54%
52-Week Low61.41
52-Week High78.85
Beta (5Y)0.62
Holdings150
Inception DateJun 13, 2016

About SHSKX

The investment seeks to provide long-term growth of capital. The fund invests at least 80% of its total assets in equity securities, primarily common stock, of companies in health sciences and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It will concentrate its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries.

Fund Family BlackRock
Category Health
Stock Exchange NASDAQ
Ticker Symbol SHSKX
Index Russell 3000 Healthcare TR

Performance

SHSKX had a total return of -14.45% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.17%.

Top 10 Holdings

51.18% of assets
NameSymbolWeight
Eli Lilly and CompanyLLY8.91%
Boston Scientific CorporationBSX6.65%
AbbVie Inc.ABBV5.98%
Abbott LaboratoriesABT5.39%
BlackRock Liquidity Funds - T-FundTSTXX5.15%
UnitedHealth Group IncorporatedUNH4.37%
Johnson & JohnsonJNJ4.13%
Stryker CorporationSYK3.99%
Amgen Inc.AMGN3.34%
Intuitive Surgical, Inc.ISRG3.27%

Dividend History

Ex-DividendAmountPay Date
Jul 17, 2025$3.83665Jul 18, 2025
Dec 11, 2024$3.38503Dec 12, 2024
Jul 18, 2024$2.49135Jul 19, 2024
Dec 7, 2023$1.39964Dec 8, 2023
Jul 20, 2023$1.34151Jul 21, 2023
Dec 8, 2022$0.28008Dec 9, 2022
Full Dividend History